Publications

You can use the filters to show only results that match your interests

Filter publications
344 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2016 to 2017

    • MHRA
    • Corporate report
  2. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Open consultation
  3. Marketing authorisations granted in June 2017

  4. Parallel import licenses granted in June 2017

  5. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  6. MHRA: business impact target

    • MHRA
    • Research and analysis
  7. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  8. Suspended and revoked licences for manufacturers and wholesalers of medicines

  9. Register of brokers authorised to deal in human medicines

  10. Human and veterinary medicines: register of licensed wholesale distribution sites

  11. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  12. Human and veterinary medicines: register of licensed manufacturing sites 2017

  13. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  14. Medicines: new manufacturing and wholesale dealer licences

  15. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  16. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  17. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  18. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  19. Notified bodies for medical devices

  20. Medical devices: UK notified bodies

  21. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  22. Better consultations, better evidence

    • MHRA
    • Research and analysis
  23. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  24. Advertising investigations: May 2017

  25. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Closed consultation
  26. Parallel import licences granted in May 2017

  27. Marketing authorisations granted in May 2017

  28. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  29. Advertising investigations: April 2017

  30. Marketing authorisations granted in April 2017

  31. Parallel import licences granted in April 2017

  32. Early access to medicines scheme (EAMS) scientific opinion: Glecaprevir/Pibrentasvir for the treatment of chronic hepatitis C (HCV) infection in adults

  33. Advertising investigations: March 2017

  34. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2016 to 2017

    • MHRA
    • Transparency data
  35. Medical devices: software applications (apps)

  36. Medicines and Healthcare products Regulatory Agency Business Plan 2017 to 18

    • MHRA
    • Corporate report
  37. Good manufacturing practice inspection deficiencies

    • MHRA
    • Official Statistics
  38. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  39. Patient group directions (PGDs)

    • MHRA
    • Guidance
  40. Parallel import licences granted in March 2017